首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Annals Of Hepatology

Annals Of Hepatology杂志,由Mexican Association of Hepatology出版,于2002年创刊,Quarterly,出版语言English,ISSN:1665-2681,E-ISSN:1665-2681。

投稿咨询
Annals Of Hepatology
Annals Of Hepatology
Annals Of Hepatology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
3区
影响因子
6.2
CiteScore
9.6
期刊收录
SCI、SCIE

Annals Of Hepatology(中文译名:《肝病学年鉴》),ISSN:1665-2681,EISSN:1665-2681,是Mexican Association of Hepatology出版的国际性学术期刊,创刊于2002年,以Quarterly形式稳定发行,2026年总发文量约88篇。该刊采用OA开放访问,学科归属为医学 - 胃肠肝病学。该刊是医学、胃肠肝病学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达6.2,2025年期刊CiteScore为9.6,2025年期刊自引率约4.8%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Annals Of Hepatology长期聚焦医学、胃肠肝病学及相关产业的技术应用前沿,平均审稿周期偏慢,4-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、胃肠肝病学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,MexicoCHINA MAINLAND、USA、Brazil、Italy、Canada、Argentina等为核心发文国家与地区;UNIVERSIDAD DE GUADALAJARAUNIVERSIDAD NACIONAL AUTONOMA DE MEXICO、UNIVERSIDADE DE SAO PAULO、PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE、MED SUR CLIN & FDN、AUSTRAL UNIVERSITY、MAYO CLINIC等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
4区

期刊分区表(2022年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 23 / 153

85.3

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 25 / 153

83.99

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 28 / 148

81.4

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 29 / 148

80.74


中国学者近期发文

1
Clostridium butyricum reduces the incidence of overt hepatic encephalopathy in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt (TIPS

Author:Xu, Xiaotong; Zhu, Tong; Jing, Changyou; Zhu, Kunlei; Meng, Qinghua; Li, Jianjun

Journal: ANNALS OF HEPATOLOGY. 2026; Vol. 31, Issue 2, pp. -. DOI: 10.1016/j.aohep.2026.102185

2
Association of nonselective β blockers with the development of hepatocellular carcinoma in liver cirrhosis: a meta-analysi

Author:Xu, Yan; Wang, Xiaohe; Li, Xiangdong; Zhao, Qingchun; Xu, Xiangbo

Journal: ANNALS OF HEPATOLOGY. 2026; Vol. 31, Issue 2, pp. -. DOI: 10.1016/j.aohep.2025.102173

3
Comment on Development of a prediction index for persistent acute kidney injury following orthotopic liver transplan

Author:Ding, Zhaoyan; Li, Yunping; Yang, Yuanming

Journal: ANNALS OF HEPATOLOGY. 2026; Vol. 31, Issue 1, pp. -. DOI: 10.1016/j.aohep.2025.102109

4
Comment on Pancreatic involvement and its prognostic impact in acute-on-chronic liver failur

Author:Yang, Yujing; Zhou, Hailian

Journal: ANNALS OF HEPATOLOGY. 2026; Vol. 31, Issue 1, pp. -. DOI: 10.1016/j.aohep.2026.102191

5
Comment on Comparisons of global incidence and risk factor profiles of hepatocellular carcinoma and intrahepatic cholangiocarcinom

Author:Wang, Zhiwei; Xiang, Lujie; Ye, Lingli; Ru, Qingjing

Journal: ANNALS OF HEPATOLOGY. 2026; Vol. 31, Issue 1, pp. -. DOI: 10.1016/j.aohep.2026.102182

6
Re-evaluating serum IL-6 as a prognostic biomarker in HCC immunotherapy with atezolizumab plus bevacizumab: the critical role of baseline liver function and disease etiolog

Author:Zou, Min; Yang, Shiye; Feng, Jinkai; Yang, Zengqiang

Journal: ANNALS OF HEPATOLOGY. 2026; Vol. 31, Issue 1, pp. -. DOI: 10.1016/j.aohep.2026.102195

7
Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinom

Author:Chan, Stephen Lam; Finn, Richard S.; Edeline, Julien; Ogasawara, Sadahisa; Knox, Jennifer J.; Daniele, Bruno; Ryoo, Baek-Yeol; Merle, Philippe; Bouattour, Mohamed; Lim, Ho-Yeong; Chao, Yee; Yau, Thomas; Haber, Barbara Anne; Malhotra, Usha; Siegel, Abby B.; Liu, Chih-Chin; Kudo, Masatoshi; Cheng, Ann-Lii

Journal: ANNALS OF HEPATOLOGY. 2026; Vol. 31, Issue 1, pp. -. DOI: 10.1016/j.aohep.2025.102169

8
Outcomes and risk of relapse after living donor and deceased donor liver transplantation for alcohol-associated liver diseas

Author:Choy, Chloe Huen Wai; Suen, Hills King Hei; Wong, Tiffany Cho Lam; Chan, Miu Yee; Au, Kin Pan; Dai, Jeff Wing Chiu; Fung, James Yan Yue; Cheung, Tan To; Chan, Albert Chi Yan

Journal: ANNALS OF HEPATOLOGY. 2026; Vol. 31, Issue 1, pp. -. DOI: 10.1016/j.aohep.2025.102177

9
Effects of artificial liver support systems on nosocomial infections and mortality in non-transplanted liver failure patient

Author:Li, Yuan; Wang, Xiaoting; Fan, Junkai; Xie, Jiale; Liu, Huimin; Ping, Chunrong; Feng, Zhijie; Wang, Yan

Journal: ANNALS OF HEPATOLOGY. 2026; Vol. 31, Issue 1, pp. -. DOI: 10.1016/j.aohep.2025.102113

10
Different measures of sodium intake and the risk of metabolic dysfunction-associated steatotic liver disease: Evidence from the UK Bioban

Author:Zhu, Shiqi; Liu, Lihe; Shen, Yiping; Li, Rui; Lin, Jiaxi; Liu, Lu; Liu, Xiaolin; Sun, Hongpeng; Zhu, Jinzhou

Journal: ANNALS OF HEPATOLOGY. 2026; Vol. 31, Issue 1, pp. -. DOI: 10.1016/j.aohep.2025.102145


在线咨询

Annals Of Hepatology

国际简称:ANN HEPATOL参考译名:肝病学年鉴

年发文量:88 CiteScore:9.6 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:93.18%

杂志社联系方式:MEXICAN ASSOC HEPATOLOGY, PUNTE DE PIEDRA 150, COLONIA TORIELLO GUERRA, MEXICO, MEXICO, DF, CP 14040

Annals Of Hepatology